06 October 2020
: Case report 
Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review
Unusual clinical course
Yanhua Yue1ABCDEFG, Wei Wei1ABCDEF, Yanting Guo1B, Fei Wang1C, Weimin Dong1D, Yue Liu1B, Yan Lin1G, Yang Cao1G, Weiying Gu1ABCDEFG*DOI: 10.12659/AJCR.925151
Am J Case Rep 2020; 21:e925151
Figure 2. Molecular findings before the first round of induction chemotherapy with modified IA. (A) Next-generation sequencing showing a JAK2 gene mutation in exon 18 (c. 2385 G >T: p.R795S). (B) Sanger sequencing showing the absence of the JAK2 R795S gene mutation in hair and nails of the same patient.